Seeking Alpha

RDUS
Radius Health, Inc. - NASDAQ

7/9/2014, 8:21 PM ET
Quote & Analysis Breaking News StockTalk
rdus chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
  • IPO Preview: Radius Health
    IPOdesktop Wed, May. 7

    Summary

    • Science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.
    • Re-tread, which originally scheduled its IPO for November '13. Re-treads generally don't perform well in the IPO aftermarket.
    • High cash burn rate, indicated by a price/earnings multiple of -6.4. A lower absolute number is worse.
    • Any negative price/earnings ratio with an absolute number below -10 is a cause for concern.
There are no Transcripts on RDUS.
RDUS vs. ETF Alternatives
Company Description
Currently, there's no company description for RDUS.
Sector: Healthcare
Industry: Biotechnology
Country: United States
OTHER NEWS